Quantification of 18 F-SynVesT-1 binding in healthy ageing and head-to-head comparison with 11 C-UCB-J

Abstract

Synaptic vesicle glycoprotein 2A (SV2A) PET imaging enables the estimation of synaptic density in the brain. The most widely used SV2A tracer, ¹¹C-UCB-J, shows age-related effects in healthy volunteers (HV) and its short radioactive half-life limits clinical applicability. ¹⁸F-SynVesT-1 has a longer half-life, but its quantification and dependence on age/sex need further validation. In this study, 40 HV aged 24–85 (21F/19M) underwent 90-min ¹⁸F-SynVesT-1 PET–MR with arterial sampling. Distribution volumes (V_T) and distribution volume ratios (DVR) were estimated using one-tissue (1TC) and two-tissue (2TC) compartment models, and Logan graphical analysis (LGA). 1TC and LGA showed strong agreement with 2TC V_T (R² ⩾ 0.97). Standardised uptake value ratios (SUVR) were evaluated across different time windows, using the centrum semiovale (CSO) and cerebellar (pseudo-)reference regions. SUVR_CSO 60–90 min correlated best with DVR_CSO. The thalamus and cingulate cortex showed age-related decreases in ¹⁸F-SynVesT-1 DVR_CSO (~2%/decade). Ten subjects (52 ± 21 years; 5F/5M) also underwent ¹¹C-UCB-J PET for a head-to-head comparison. ¹⁸F-SynVesT-1 showed lower cortical V_T (−7% ± 9%) but higher DVR_CSO (37% ± 4%). This study shows that ¹⁸F-SynVesT-1 can be reliably quantified by SUVR in healthy volunteers, and correlates well with ¹¹C-UCB-J. These findings support the broader application of ¹⁸F-SynVesT-1. This study was registered on clinicaltrial.gov (NCT05384353).

Keywords

Ageing kinetic modelling SV2A SynVesT-1 UCB-J

Get full access to this article

View all access options for this article.

References

Bajjalieh

Frantz

Weimann

, et al. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci 1994; 14(9): 5223–5235.

Finnema

Nabulsi

Eid

, et al. Imaging synaptic density in the living human brain. Sci Transl Med 2016; 8: 348ra96.

Nabulsi

Mercier

Holden

, et al. Synthesis and preclinical evaluation of ¹¹C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain. J Nucl Med 2016; 57: 777–784.

Michiels

Delva

Van Aalst

, et al. Synaptic density in healthy human aging is not influenced by age or sex: a ¹¹C-UCB-J PET study. Neuroimage 2021; 232: 117877.

Andersen

Hansen

Knudsen

, et al. Healthy brain aging assessed with [¹⁸F]FDG and [¹¹C]UCB-J PET. Nucl Med Biol 2022; 112–113: 52–58.

Toyonaga

Khattar

, et al. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [¹¹C]UCB-J. Eur J Nucl Med Mol Imaging 2024; 51: 1012–1022.

Carson

Naganawa

Toyonaga

, et al. Imaging of synaptic density in neurodegenerative disorders. J Nucl Med 2022; 63: 60S–67S.

Vanderlinden

Koole

Michiels

, et al. Longitudinal synaptic loss versus tau Braak staging in amnestic mild cognitive impairment. Alzheimers Dement 2025; 21: e14412.

Mecca

Chen

O’Dell

, et al. In vivo measurement of widespread synaptic loss in Alzheimer’s disease with SV2A PET. Alzheimers Dement 2020; 16(7): 974–982.

10.

Delva

Van Laere

Vandenberghe

Longitudinal positron emission tomography imaging of presynaptic terminals in early Parkinson’s disease. Mov Disord 2022; 37(9): 1883–1892.

11.

Delva

Van Laere

Vandenberghe

Longitudinal imaging of regional brain volumes, SV2A, and glucose metabolism in Huntington’s disease. Mov Disord 2023; 38(8): 1515–1526.

12.

Mecca

O’Dell

Sharp

, et al. Synaptic density and cognitive performance in Alzheimer’s disease: a PET imaging study with [¹¹C]UCB-J. Alzheimers Dement 2022; 18: 2527–2536.

13.

Holmes

Honhar

Tinaz

, et al. Synaptic loss and its association with symptom severity in Parkinson’s disease. NPJ Parkinsons Dis 2024; 10: 42.

14.

Delva

Michiels

Koole

, et al. Synaptic damage and its clinical correlates in people with early Huntington disease: a PET study. Neurology 2022; 98: e83–e94.

15.

Naganawa

Nabulsi

, et al. First-in-human evaluation of ¹⁸F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A. J Nucl Med 2021; 62(4): 561–567.

16.

Naganawa

Gallezot

, et al. Noninvasive quantification of [¹⁸F]SynVesT-1 binding using simplified reference tissue model 2. Eur J Nucl Med Mol Imaging 2024; 52: 113–121.

17.

Michiels

Mertens

Thijs

, et al. Changes in synaptic density in the subacute phase after ischemic stroke: a ¹¹C-UCB-J PET/MR study. J Cereb Blood Flow Metab 2021; 42(2): 303–314.

18.

Koole

Van Aalst

Devrome

, et al. Quantifying SV2A density and drug occupancy in the human brain using [¹¹C]UCB-J PET imaging and subcortical white matter as reference tissue. Eur J Nucl Med Mol Imaging 2019; 46: 396–406.

19.

Finnema

Nabulsi

Mercier

, et al. Kinetic evaluation and test–retest reproducibility of [¹¹C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans. J Cereb Blood Flow Metab 2018; 38(11): 2041–2052.

20.

Mertens

Michiels

Vanderlinden

, et al. Impact of meningeal uptake and partial volume correction techniques on [¹⁸F]MK-6240 binding in aMCI patients and healthy controls. J Cereb Blood Flow Metab 2022; 41(11): 1–11.

21.

Giorgio

Soleimani-Meigooni

Janabi

, et al. Imaging synaptic density in aging and Alzheimer disease with [¹⁸F]SynVesT-1. J Nucl Med 2025; 66: 620–625.

22.

Lin

Bao

, et al. Head-to-head comparison of [¹⁸F]FDG, [¹⁸F]FMZ, and [¹⁸F]SynVesT-1 positron emission tomography imaging in patients with drug-resistant epilepsy. Eur J Nucl Med Mol Imaging 2025; 52: 2258–2266.

23.

Rossano

Toyonaga

Finnema

, et al. Assessment of a white matter reference region for ¹¹C-UCB-J PET quantification. J Cereb Blood Flow Metab 2020; 40(9): 1890–1901.

24.

Young

O’Dell

Naganawa

, et al. Validation of a simplified tissue-to-reference ratio measurement using SUVR to assess synaptic density alterations in Alzheimer disease with [¹¹C]UCB-J PET. J Nucl Med 2024; 65: 1782–1785.

25.

Muer

Didier

Wannebo

, et al. Sex differences in gray matter, white matter, and regional brain perfusion in young, healthy adults. Am J Physiol Heart Circ Physiol 2024; 327: H847–H858.

26.

Cai

Zhang

, et al. Synthesis and in vivo evaluation of [¹⁸F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A). Eur J Nucl Med Mol Imaging 2019; 46(9): 1965.

27.

Badawi

Cherry

, et al. Performance characteristics of the NeuroEXPLORER, a next-generation human brain PET/CT imager. J Nucl Med 2024; 65(8): 1320–1326.

28.

Volpi

Toyonaga

Khattar

, et al. Exceptional brain PET images from the NeuroEXPLORER: scans with targeted radiopharmaceuticals and comparison to HRRT. Eur J Nucl Med Mol Imaging 2026; 53(3): 2110–2121.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

1.87 MB

0.00 MB